We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Nanoneedle Bio-patch Provides Minimally Invasive Drug Delivery

By LabMedica International staff writers
Posted on 20 Nov 2018
A flexible bio-patch made from silicon nanoneedles embedded in a thin layer of elastomer was shown to deliver exact doses of biomolecules to cells and tissues while minimizing discomfort to the wearer.

Vertically ordered arrays of silicon nanoneedles – due to their nanoscale dimension and low cytotoxicity – are capable of minimally invasive nanoinjection of biomolecules into living biological systems such as cells and tissues. More...
Nanoneedle bio-patches are usually fabricated on a bulk silicon wafer that is able to withstand the high temperatures and corrosive chemicals employed in standard nanofabrication processes. These rigid, flat, and opaque silicon wafers do not conform favorably with the soft, curvilinear, and optically transparent biological systems for which they are intended.

To improve this situation, investigators at Purdue University (West Lafayette, IN, USA) developed a unique methodology that enabled construction of vertically ordered silicon nanoneedles on a thin layer of elastomer patch that could flexibly and transparently interface with biological systems.

The investigators reported in the November 9, 2018, online edition of the journal Science Advances that this methodology allowed the heterogeneous integration of vertically ordered silicon nanoneedles with a thin layer of elastomer patch, which could provide a certain degree of mechanical flexibility, optical transparency, and cell and tissue compatibility.

"This means that eight or nine silicon nanoneedles can be injected into a single cell without significantly damaging a cell. So we can use these nanoneedles to deliver biomolecules into cells or even tissues with minimal invasiveness," said senior author Dr. Chi Hwan Lee, assistant professor in of biomedical engineering at Purdue University. "This nanoneedle patch is not only flexible but also transparent, and therefore can also allow simultaneous real-time observation of the interaction between cells and nanoneedles."

Related Links:
Purdue University


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.